Nutriband Inc. (NTRB)
Makes fentanyl patches for chronic pain treatment.
$2.96-0.01%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-60.0%
The outlook
NTRB is trading near its 52-week low, well below both its 50- and 200-day moving averages, reflecting a weak near-term trend. Analyst coverage is sparse, but the average price target sits roughly 408% above the current price, suggesting a wide gap between current market valuation and analyst estimates. The overall sentiment remains bearish at present.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range1% of the way from its 52-week low to high
Price targetAvg target +408% vs current price
Market cap
$35.9M
52-wk high
$8.63
52-wk low
$2.90
50-day avg
$3.26
200-day avg
$4.40
Trailing P/E
—